Market Trends of UAE Neurology Devices Industry
Neurostimulation Devices Segment is Expected to Witness Significant Growth Over the Forecast Period
Neurostimulation devices are considered implantable and programmable medical devices that deliver electrical stimulation effectively to specific parts of the patient's brain, spinal cord, or peripheral nervous system to help treat various conditions, including chronic pain and movement disorders. Hence, with increasing incidences of various diseases such as overactive bladder and urinary incontinence, the neurostimulation devices segment is expected to grow during the forecast period.
According to an article published by PubMed Central in December 2022, a study conducted in the United Arab Emirates showed that the quality of life was affected in an estimated 90% of the patients suffering from urinary incontinence. Thus, the increasing burden of urinary incontinence is expected to boost the usage of nerve stimulation, as nerve stimulation is widely used in the treatment of urinary incontinence.
Furthermore, according to an article published by Cureus in May 2022, a study was conducted in the country that examined the prevalence of urinary incontinence in women. It was found that the prevalence of urinary incontinence was 42.2% among women. Moreover, the rising adult and geriatric population in the country is also expected to boost segment growth, as these diseases are mainly associated with these age groups.
Hence, the aforementioned factors, such as the rising prevalence of fecal incontinence and urinary incontinence and the rising adult and geriatric population, are expected to boost the segment’s growth during the forecast period.
Neurosurgery Devices Segment is Expected to Witness Significant Growth During the Forecast Period
Neurosurgery devices are devices that are used for the surgical treatment of various brain and spinal cord diseases. These devices are mainly used for the treatment of various neurological diseases such as dystonia, Alzheimer's disease, Parkinson's disease, and epilepsy, among others. The rising prevalence of such neurological disorders in the country and the rising geriatric population are expected to boost segment growth.
According to an article published by the Multidisciplinary Digital Publishing Institute (MDPI) in August 2022, a study was conducted in the country, which showed that the prevalence rate of Parkinson's disease is high in the country. Early diagnosis and prompt treatment initiation are important, as they have a huge socio-economic impact in the country. Thus, the high prevalence of Parkinson's disease in the country is expected to boost segment growth.
Furthermore, according to a new study released by the Lancet Public Health in January 2022, the United Arab Emirates and other Gulf countries were predicted to report the highest increases in the number of people living with dementia over the next 30 years worldwide. It was estimated that the United Arab Emirates will witness an increase of 1,795% in people suffering from dementia by 2050. Thus, the high number of dementia cases is expected to increase the prevalence of Alzheimer's disease in the region over the forecast period, thereby propelling market growth.
Therefore, the aforementioned factors, such as the rising prevalence of Alzheimer's and Parkinson's diseases and the rising geriatric population, are expected to boost the segment’s growth during the forecast period.
